Bio-Rad Laboratories, Inc. (BIO) has a consensus analyst rating of Buy, based on 14 analysts covering the stock. Of those, 8 recommend buying, 6 recommend holding, and 0 recommend selling.
The analyst consensus price target for BIO is $327.50, representing a +12.1% upside from the current price of $292.23. Price targets range from a low of $320.00 to a high of $335.00.
